Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Horak

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Genes, Chromosomes & Cancer|June 6, 2020
Germline SDHB-inactivating mutation in gastric spindle cell sarcomaChristoph E Heilig, Peter Horak, Daniel B Lipka, et al.
NPJ Precision Oncology|January 10, 2025
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologyIrina A Kerle, Thomas Gross, Anja Kögler, et al.
JCO Precision Oncology|May 26, 2021
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast CancerMario Hlevnjak, Markus Schulze, Shaymaa Elgaafary, et al.
Nature Communications|May 10, 2020
The landscape of chromothripsis across adult cancer typesNatalia Voronina, John K L Wong, Daniel Hübschmann, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2021
Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical fieldAnna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, et al.
Science Advances|September 1, 2023
BRAF<sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggabilityManuel Lauinger, Daniel Christen, Rhena F U Klar, et al.
International Journal of Cancer|June 10, 2017
Precision oncology based on omics data: The NCT Heidelberg experiencePeter Horak, Barbara Klink, Christoph Heining, et al.
International Journal of Molecular Sciences|May 14, 2022
Recurrent Germline Variant in <i>RAD21</i> Predisposes Children to Lymphoblastic Leukemia or LymphomaAnne Schedel, Ulrike Anne Friedrich, Mina N F Morcos, et al.
NPJ Precision Oncology|October 26, 2023
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncologyAndreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, et al.
Med (New York, N.Y.)|May 1, 2026
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasmsSimon Kreutzfeldt, Leonidas Apostolidis, Małgorzata Oleś, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Genes, Chromosomes & Cancer|June 6, 2020
Germline SDHB-inactivating mutation in gastric spindle cell sarcomaChristoph E Heilig, Peter Horak, Daniel B Lipka, et al.
NPJ Precision Oncology|January 10, 2025
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologyIrina A Kerle, Thomas Gross, Anja Kögler, et al.
JCO Precision Oncology|May 26, 2021
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast CancerMario Hlevnjak, Markus Schulze, Shaymaa Elgaafary, et al.
Nature Communications|May 10, 2020
The landscape of chromothripsis across adult cancer typesNatalia Voronina, John K L Wong, Daniel Hübschmann, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2021
Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical fieldAnna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, et al.
Science Advances|September 1, 2023
BRAF<sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggabilityManuel Lauinger, Daniel Christen, Rhena F U Klar, et al.
International Journal of Cancer|June 10, 2017
Precision oncology based on omics data: The NCT Heidelberg experiencePeter Horak, Barbara Klink, Christoph Heining, et al.
International Journal of Molecular Sciences|May 14, 2022
Recurrent Germline Variant in <i>RAD21</i> Predisposes Children to Lymphoblastic Leukemia or LymphomaAnne Schedel, Ulrike Anne Friedrich, Mina N F Morcos, et al.
NPJ Precision Oncology|October 26, 2023
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncologyAndreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, et al.
Med (New York, N.Y.)|May 1, 2026
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasmsSimon Kreutzfeldt, Leonidas Apostolidis, Małgorzata Oleś, et al.
Pageof 14